Clinical Trial Update: A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating regimens containing GW433908 (fosamprenavir) in HIV-1 infected subjects has completed, and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fosamprenavir (fosamprenavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2011-11-08